The Edwards Benchmark program is a systematic, evidence-based approach to optimize TAVI

Protocols and best practices
developed to optimize all stages of the clinical pathway: pre, peri, post procedure
Peer to peer learning journey
between program faculties and the Multidisciplinary Heart Teams to determine specific goals and achieve them
Enabling safe and early discharge home, instilling Heart Team efficiency

Edwards Benchmark Program targets 6 meaningful clinical outcomes

1% 30-day Mortality3
1% 30-day Stroke3
1.5% 30-day Major Vascular Complications1
6% 30-day Permanent Pacemaker Implants4
4% 30-day Cardiac Readmissions3
80% Next-Day Discharge Home4
Edwards Benchmark Program targets 6 meaningful clinical outcomes

Watch a patient journey through Edwards Benchmark program

Edwards Benchmark program brochure with infographics

Edwards Benchmark program best practices

Risk-stratified case selection and patients'family educ
A more efficient pre-procedure planning
Evidence-based peri-procedural protocols1,2
Achieve excellent clinical outcomes
Standardised post-procedural protocols1,2
Safe early discharge, improved Quality of Life
Bringing together the TAVI community worldwide
Best practice sharing, in pursuit of higher standards and goals
View Edwards Benchmark program brochure
Male interventional cardiologist researching on his laptop

See the 2022 EuroPCR Benchmark symposium

Watch symposium
Male interventional cardiologist researching on his laptop

How TAVI demonstrates excellent patient safety outcomes without additional resource usage

View evidence from the 3M study3

For more information email us at

Stay informed with our newsletter


1. Lauck, S.B.; Wood, D.A.; Baumbusch, J.; et al. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay. Circ Cardiovasc Qual Outcomes 2016;9:312-321.
2. Butala N. Economics of minimalist TAVR: The 3M TAVR Economic Study. TCT presentation 2021.
3. Barbanti, M; van Mourik, M.S.; Spence, M.S.; et al. Optimizing Patient Discharge Management after Transfemoral Transcatheter Aortic Valve Implantation: The Multicentre European FAST- TRANSCATHETER AORTIC VALVE IMPLANTATION Trial. EuroIntervention 2019;15(2):147-154.
4. Wood, D.A.; Lauck, S.B.; Cairns, J.A.; et al. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-volume Transfemoral Transcatheter Aortic Valve Replacement Centers: the 3M TAVR Study. J Am Coll Cardiol Intv 2019;12:459-469.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult where applicable).

PP--EU-3358 v1.0